Metraipolis › archive › dc_c67cc0e30dcb

Use of central nervous system drugs in combination with selective serotonin reuptake inhibitor treatment: A Bayesian screening study for risk of suicidal… — Europe PMC PMID:36440412

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/36440412
DOI
10.3389/fpsyt.2022.1012650
License (as archived)
solo-consultazione
Archived
2026-10-09T22:41:39.252Z
SHA-256 of the archived text
b054689da0d3f558144edf49f0daabb72b7852f24b97c00e311260b0f0c273c7
Stable URL of this page
https://metraipolis.com/documento/dc_c67cc0e30dcb

How to cite

Use of central nervous system drugs in combination with selective serotonin reuptake inhibitor treatment: A Bayesian screening study for risk of suicidal… — Europe PMC PMID:36440412 — Europe PMC (en), https://europepmc.org/article/MED/36440412 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c67cc0e30dcb (Metraipolis archive dc_c67cc0e30dcb, sha256 b054689da0d3f558144edf49f0daabb72b7852f24b97c00e311260b0f0c273c7)
BibTeX
@misc{dcc67cc0e30dcb,
  title = {Use of central nervous system drugs in combination with selective serotonin reuptake inhibitor treatment: A Bayesian screening study for risk of suicidal… — Europe PMC PMID:36440412},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/36440412},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c67cc0e30dcb; sha256 b054689da0d3f558144edf49f0daabb72b7852f24b97c00e311260b0f0c273c7},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/36440412. Agents can read the archived copy with the MCP tool read_document.